DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Virtual Event

2020年11月08日 (日) 午前 9:30 - 2020年11月10日 (火) 午後 5:40

Nihonbashi Life Science Building 6F, 2-3-11 Nihonbashihoncho, Chuo-ku, Tokyo, 103-0023 Japan

17th DIA Japan Annual Meeting 2020

アジェンダ

9:30 AM10:00 AM

LS01 Opening

9:30 AM5:30 PM

OS03 Real World Data: Concrete Utilization Examples and Issues_E

9:30 AM5:30 PM

OS06 Challenge of Incorporating Patient Perspective in Drug Development: Lessons Learned from “System of Patient Engagement inRregulatory Review” by US Food and Drug Administration/European Medicines Agency_E

9:30 AM5:30 PM

OS07 Hot Topics in Using RWD in Drug Development_E

9:30 AM5:30 PM

OS08 What’s Needed to Transform Flow of Information in Clinical Development_E

9:30 AM5:30 PM

OS10 Considerations for Utilizing Wearable Sensors in Clinical Research_E

9:30 AM5:30 PM

OS12 Changes Accelerated by Innovation: Clinical Operation & Data Management_E

9:30 AM5:30 PM

OS16 What is the Quality of Real World Evidence?_E

10:15 AM11:45 AM

LS02 Quantitative Decision Making in Drug Development_E

10:15 AM11:15 AM

SLS01 ICH 30th Anniversary: Summary of 30 Years and Future Prospects with the Role of Japan_E

1:45 PM3:15 PM

SLS03 ICH Anniversary: Summary of 30 Years and Future Prospects in Q Ar_ea with the Role of Japan_E

3:30 PM4:30 PM

SLS04 Scientific Benefit-Risk Management and Communication for the Future_E

3:30 PM5:00 PM

SLS05 ICH Anniversary: Summary of 30 Years and Future Prospects in S Area with Role of Japan_E

9:00 AM10:30 AM

LS09 Driving Toward Further Operational Efficiency and Innovation in Clinical Trials_E

9:00 AM10:30 AM

SLS08 ICH Anniversary: Summary of 30 Years and Future Prospects in E Area with Role of Japan_E

10:45 AM12:15 PM

LS11 Keynote Address: Patient-Focused Drug Development_E

10:45 AM11:45 AM

SLSx09

12:45 PM1:45 PM

SLS11 How Can industry Play a Role through Publications to Elevate Patient Voice?_E

12:45 PM2:15 PM

SLS12 ICH Anniversary: Summary of 30 years and Future Prospects in M Area with Role of Japan_E

12:45 PM2:15 PM

SLS13 Impact of Patient Engagement Initiatives in Clinical Trial Design and Execution_E

4:15 PM5:15 PM

SLS14 WHAT’S NEW? Risk Communication and Pharmaceutical Information in the Digital Era in Japan, Europe, and the US_E

4:15 PM5:15 PM

SLS16

5:30 PM8:00 PM

LS17 Special Chat Session

12:45 PM1:45 PM

SLS23 How to Promote Use of Centralized IRB in Clinical Trials_E

5:15 PM5:30 PM

LS25 Closing Remarks

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。